A single amino acid difference in human APOBEC3H variants determines HIV-1 Vif sensitivity.

Journal of Virology
Anjie ZhenXiao-Fang Yu

Abstract

Several variants of APOBEC3H (A3H) have been identified in different human populations. Certain variants of this protein are particularly potent inhibitors of retrotransposons and retroviruses, including HIV-1. However, it is not clear whether HIV-1 Vif can recognize and suppress the antiviral activity of A3H variants, as it does with other APOBEC3 proteins. We now report that A3H_Haplotype II (HapII), a potent inhibitor of HIV-1 in the absence of Vif, can indeed be degraded by HIV-1 Vif. Vif-induced degradation of A3H_HapII was blocked by the proteasome inhibitor MG132 and a Cullin5 (Cul5) dominant negative mutant. In addition, Vif mutants that were incapable of assembly with the host E3 ligase complex factors Cul5, ElonginB, and ElonginC were also defective for A3H_HapII suppression. Although we found that Vif hijacks the same E3 ligase to degrade A3H_HapII as it does to inactivate APOBEC3G (A3G) and APOBEC3F (A3F), more Vif motifs were involved in A3H_HapII inactivation than in either A3G or A3F suppression. In contrast to A3H_HapII, A3H_Haplotype I (HapI), which differs in only three amino acids from A3H_HapII, was resistant to HIV-1 Vif-mediated degradation. We also found that residue 121 was critical for determining A3H s...Continue Reading

References

Dec 5, 1993·Journal of Molecular Biology·A Sali, T L Blundell
May 17, 2003·Science·Denise LecossierAllan J Hance
Jun 18, 2003·Cell·Reuben S HarrisMichael H Malim
Jul 16, 2003·Cell·Roberto MarianiNathaniel R Landau
Oct 7, 2003·Nature Medicine·Mariana MarinDavid Kabat
Nov 15, 2003·Current Biology : CB·Silvestro G ConticelloMichael S Neuberger
Feb 18, 2004·The Journal of Biological Chemistry·Bastien MangeatDidier Trono
Feb 24, 2004·Proceedings of the National Academy of Sciences of the United States of America·Bärbel SchröfelbauerNathaniel R Landau
Mar 5, 2004·Proceedings of the National Academy of Sciences of the United States of America·Hal P BogerdBryan R Cullen
Mar 20, 2004·Science·Priscilla TurelliDidier Trono
Mar 23, 2004·Nucleic Acids Research·Robert C Edgar
Apr 1, 2004·Proceedings of the National Academy of Sciences of the United States of America·Hongzhan XuVinay K Pathak
Apr 21, 2004·Nature Structural & Molecular Biology·Qin YuNathaniel R Landau
May 4, 2004·Nucleic Acids Research·Rodolphe SuspèneJean-Pierre Vartanian
May 14, 2004·Journal of Virology·Yong-Hui ZhengB Matija Peterlin
Jul 16, 2004·Journal of Virology·Masayuki KobayashiTakashi Uchiyama
Aug 7, 2004·Current Biology : CB·Mark T LiddamentReuben S Harris
Aug 7, 2004·Current Biology : CB·Kate N BishopMichael H Malim
Sep 9, 2004·Science·Christine RöslerFritz von Weizsäcker
Oct 7, 2004·The Journal of Biological Chemistry·Qin YuNathaniel R Landau
Oct 22, 2004·Molecular Biology and Evolution·Silvestro G ConticelloMichael S Neuberger
Oct 22, 2004·Nature Immunology·Paul D Bieniasz
Nov 2, 2004·Nature Reviews. Immunology·Reuben S Harris, Mark T Liddament
Dec 22, 2004·Molecular Cell·Stephen P Goff
Jan 26, 2005·Current Biology : CB·Edmund N C NewmanAnn M Sheehy
Feb 19, 2005·Science·Priscilla Turelli, Didier Trono
Feb 24, 2005·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Chiemi NoguchiKazuaki Chayama
May 26, 2005·Virology·Melanie KremerBarbara S Schnierle
May 28, 2005·Proceedings of the National Academy of Sciences of the United States of America·Rodolphe SuspèneJean-Pierre Vartanian
Jul 8, 2005·Proceedings of the National Academy of Sciences of the United States of America·April J SchumacherReuben S Harris
Aug 4, 2005·Proceedings of the National Academy of Sciences of the United States of America·Kun LuoXiao-Fang Yu
Aug 17, 2005·Journal of Virology·Bärbel SchröfelbauerNathaniel R Landau
Jan 13, 2006·The Journal of Biological Chemistry·Ya-Lin Chiu, Warner C Greene
Jan 13, 2006·Nucleic Acids Research·Hal P BogerdBryan R Cullen

❮ Previous
Next ❯

Citations

Sep 25, 2012·Nature Structural & Molecular Biology·Shingo KitamuraYasumasa Iwatani
Oct 26, 2010·The Journal of Biological Chemistry·John S AlbinReuben S Harris
Jan 29, 2011·Journal of Virology·Xiaojun WangYong-Hui Zheng
Jan 16, 2013·Journal of Molecular Biology·John S AlbinReuben S Harris
Jun 26, 2012·Virus Research·Julien BatisseJean-Christophe Paillart
Oct 26, 2011·Evolution; International Journal of Organic Evolution·Rachele CaglianiManuela Sironi
Nov 13, 2015·Journal of Human Genetics·Taeko K NaruseAkinori Kimura
Mar 25, 2014·Structure·Halil AydinJeffrey E Lee
Aug 16, 2014·Trends in Biochemical Sciences·Jason D SalterHarold C Smith
Nov 6, 2013·Journal of Molecular Biology·Belete A DesimmieVinay K Pathak
Sep 11, 2014·Frontiers in Microbiology·Yuqing FengLinda Chelico
Sep 24, 2015·The Journal of Biological Chemistry·Yuqing FengLinda Chelico
Dec 30, 2016·Journal of Virology·Marcel OomsViviana Simon
Jun 10, 2015·Antimicrobial Agents and Chemotherapy·Claudia AlteriValentina Svicher
Oct 3, 2014·Journal of Virology·Tayyba T BaigLinda Chelico
Jul 8, 2011·Current Opinion in HIV and AIDS·Magdalena E SobieszczykM Juliana McElrath
Nov 20, 2014·Archives of Pharmacal Research·Dong Young Kim
Sep 14, 2012·The Journal of Immunology : Official Journal of the American Association of Immunologists·Harshini V MehtaChioma M Okeoma
Jan 21, 2019·BMC Medical Genetics·Nontokozo D MatumeMarie-Louise Hammarskjöld
Oct 19, 2017·Nature Communications·Jennifer A BohnJanet L Smith

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antivirals

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Antivirals (ASM)

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.